{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:35:29Z","timestamp":1792697729597,"version":"4.5.0"},"reference-count":128,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00078","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T23:57:13Z","timestamp":1582675033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["NBOMes\u2013Highly Potent and Toxic Alternatives of LSD"],"prefix":"10.3389","volume":"14","author":[{"given":"Jolanta B.","family":"Zawilska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kacela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Adamowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.bbr.2018.07.020","article-title":"5-Methoxy-\u03b1-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex.","volume":"359","author":"Abiero","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0893-133X(98)00135-3","article-title":"Serotonin and hallucinogens.","author":"Aghajanian","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"B3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5539\/gjhs.v9n11p126","article-title":"NBOMe compounds: systematic review and data crunching of the surface web.","volume":"9","author":"Al-Iman","year":"2017","journal-title":"Glob. J. Health Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2174\/1389201019666171129175148","article-title":"Retrospective demonstration of 25I-NBOMe acute poisoning using hair analysis.","volume":"18","author":"Ameline","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.emc.2015.07.006","article-title":"New drugs of abuse and withdrawal syndromes.","volume":"33","author":"Andrabi","year":"2015","journal-title":"Emerg. Med. Clin. North Am."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2015.03.012","article-title":"A fatal poisoning involving 25C-NBOMe.","volume":"251","author":"Andreasen","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1201\/9781315313177-16","article-title":"NBOMe derivatives of phenylethylamines and their analysis","author":"Anilanmert","year":"2018","journal-title":"Chromatographic Techniques in the Forensic Analysis of Designer Drugs"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/734749","article-title":"25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug.","volume":"2014","author":"Bersani","year":"2014","journal-title":"Biomed Res. Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1471-4159.2005.03485.x","article-title":"The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.","volume":"95","author":"Bortolozzi","year":"2005","journal-title":"J. Neurochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.","volume":"70","author":"Braden","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jpba.2016.11.040","article-title":"Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MSn, and LC\u2013HR\u2013MS\/MS approaches.","volume":"134","author":"Caspar","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1007\/s00216-015-8828-6","article-title":"Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS\/MS.","volume":"407","author":"Caspar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.talanta.2017.08.063","article-title":"Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry.","volume":"176","author":"Caspar","year":"","journal-title":"Talanta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2017.12.017","article-title":"Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach.","volume":"285","author":"Caspar","year":"","journal-title":"Toxicol. Lett."},{"key":"B15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.talanta.2018.05.064","article-title":"Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.","volume":"188","author":"Caspar","year":"","journal-title":"Talanta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00216-017-0526-0","article-title":"LC-high resolution-MS\/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl]propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.","volume":"410","author":"Caspar","year":"","journal-title":"Anal. Bioanal. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.clinbiochem.2017.02.016","article-title":"Non-traumatic rhabdomyolysis: background, laboratory features, and acute clinical management.","volume":"50","author":"Cervellin","year":"2017","journal-title":"Clin. Biochem."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.109892","article-title":"Fatalities related to new psychoactive substances in Singapore \u2013 A case series.","author":"Chan","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.forsciint.2019.05.036","article-title":"Simultaneous analysis of 2Cs, 25-NBOHs, 25-NBOMes and LSD in seized exhibits using liquid chromatography-tandem mass spectrometry: a targeted approach.","volume":"301","author":"Chia","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12850","article-title":"25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: evidence of abuse potential.","author":"Custodio","year":"2019","journal-title":"Addict. Biol."},{"key":"B21","year":"2018","journal-title":"25I-NBOMe, 25C-NBOMe, and 25B-NBOMe (Street Names: N-bomb, Smiles, 25I, 25C, 25B)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuropharm.2018.02.033","article-title":"Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.","volume":"142","author":"Elmore","year":"2018","journal-title":"Neuropharmacology"},{"key":"B23","year":"2014","journal-title":"Report on the Risk Assessment of 2-(4-iodo-2,5-Dimethoxyphenyl)-N-(2-Methoxybenzyl)Ethanamine (25I-NBOMe) in the Framework of the Council Decision on New Psychoactive Substances."},{"key":"B24","year":"2019","journal-title":"European Drug Report 2019: Trends and Developments."},{"key":"B25","year":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bcp.2018.09.024","article-title":"Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: high potency agonists at 5-HT2A receptors.","volume":"158","author":"Eshleman","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/jcbfm.2014.68","article-title":"Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36.","volume":"34","author":"Ettrup","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2967\/jnumed.109.074021","article-title":"Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.","volume":"51","author":"Ettrup","year":"2010","journal-title":"J. Nucl. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/10550887.2014.950027","article-title":"NBOMe designer drug exposures reported to Texas poison centers.","volume":"33","author":"Forrester","year":"2014","journal-title":"J. Addict. Dis."},{"key":"B30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/FBP.0000000000000309","article-title":"Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.","volume":"28","author":"Gatch","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3109\/15563650.2015.1115056","article-title":"Case series: toxicity from 25B-NBOMe \u2013 a cluster of N-bomb cases.","volume":"54","author":"Gee","year":"2016","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/dta.2446","article-title":"In vitro phase I metabolism of three phenethylamines 25D-NBOMe, 25E-NBOMe and 25N-NBOMe using microsomal and microbial models.","volume":"10","author":"Grafinger","year":"2018","journal-title":"Drug Test. Anal."},{"key":"B34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00063-014-0360-5","article-title":"Near fatal intoxication with the novel psychoactive substance 25C-NBOMe.","volume":"109","author":"Grautoff","year":"2014","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"B35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/7854_2016_64","article-title":"Pharmacology and toxicology of N-benzylphenethylamine (\u201cNBOMe\u201d) hallucinogens.","volume":"32","author":"Halberstadt","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00213-009-1718-x","article-title":"LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor.","volume":"208","author":"Halberstadt","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","article-title":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.","volume":"77","author":"Halberstadt","year":"2014","journal-title":"Neuropharmacology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior.","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1021\/cn400216u","article-title":"Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A\/2C agonists.","volume":"5","author":"Hansen","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B40","author":"Heim","year":"2003","journal-title":"Synthese und Pharmakologie Potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur."},{"key":"B41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12640-019-00033-x","article-title":"Hallucinogen-like action of the novel designer drug 25I-NBOMe and its effect on cortical neurotransmitters in rats.","volume":"36","author":"Herian","year":"2019","journal-title":"Neurotox. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/15563650.2017.1319572","article-title":"Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.","volume":"55","author":"Hermanns-Clausen","year":"2017","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2015.04.065","article-title":"Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series.","volume":"33","author":"Hieger","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/15563650.2013.802795","article-title":"Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.","volume":"51","author":"Hill","year":"2013","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.14740\/jmc2811w","article-title":"Toxic leukoencephalopathy in a teenager caused by the recreational ingestion of 25I-NBOMe: a case report and review of literature.","volume":"8","author":"Humston","year":"2017","journal-title":"J. Med. Cases"},{"key":"B46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/ci100402f","article-title":"G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations.","volume":"51","author":"\u00cdsberg","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuint.2019.02.007","article-title":"Abuse potential of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe); in vivo and ex vivo approaches.","volume":"125","author":"Jeon","year":"2019","journal-title":"Neurochem. Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jat\/bku085","article-title":"An evaluation of 25B-, 25C-, 25D-, 25H-, 25I- and 25T2-NBOMe via LC-MS-MS: method validation and analyte stability.","volume":"38","author":"Johnson","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/cn3000668","article-title":"Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.","volume":"14","author":"Juncosa","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/jat\/bkw035","article-title":"Detection of 25C-NBOMe in three related cases.","volume":"40","author":"Kristofic","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.forsciint.2015.02.010","article-title":"25I-NBOMe related death in Australia: a case report.","volume":"249","author":"Kueppers","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"B52","first-page":"3270","article-title":"NBOMe: new potent hallucinogens\u2013pharmacology, analytical methods, toxicities, fatalities: a review.","volume":"19","author":"Kyriakou","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1177\/0269881114523866","article-title":"The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample.","volume":"28","author":"Lawn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/acs.chemrestox.5b00450","article-title":"Metabolic fate of hallucinogenic NBOMes.","volume":"29","author":"Leth-Petersen","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jat\/bkv092","article-title":"A case review of the first analytically confirmed 25I-NBOMe-related death in Washington state.","volume":"39","author":"Lowe","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"B56","article-title":"NBOMe hallucinogenic drug exposures reported to the Danish Poison Information Centre.","volume":"64","author":"Madsen","year":"2017","journal-title":"Dan. Med. J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2018.11.002","article-title":"Clinical and toxicological profile of NBOMes: a systematic review.","volume":"60","author":"Marchi","year":"2019","journal-title":"Psychosomatics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11419-018-0444-7","article-title":"MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity.","volume":"37","author":"Marti","year":"2019","journal-title":"Forensic Toxicol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.109969","article-title":"Mix of new substances psychoactive, NPS, found in blotters sold in two Colombian cities.","author":"Mendoza-Valencia","year":"2019","journal-title":"Forensic Sci. Int."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fpharm.2019.01406","article-title":"Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe.","volume":"10","author":"Miliano","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.forsciint.2017.08.028","article-title":"Death after 25C-NBOMe and 25H-NBOMe consumption.","volume":"279","author":"Morini","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2004.07.044","article-title":"Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.","volume":"1023","author":"Muschamp","year":"2004","journal-title":"Brain Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/cn500292d","article-title":"N-Benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues.","volume":"6","author":"Nichols","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/dta.2031","article-title":"Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.","volume":"9","author":"Nielsen","year":"2017","journal-title":"Drug Test. Anal."},{"key":"B65","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/01480545.2014.911882","article-title":"2C-I-NBOMe, an \u201cN-bomb\u201d that kills with \u201cSmiles\u201d. Toxicological and legislative aspects.","volume":"38","author":"Nikolaou","year":"2015","journal-title":"Drug Chem. Toxicol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/jat\/bky109","article-title":"Gas chromatography-mass spectrometry method for the quantitative identification of 23 new psychoactive substances in blood and urine.","volume":"43","author":"Nisbet","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s12640-016-9654-0","article-title":"Neurotoxic effects of 5-MeO-DIPT: a psychoactive tryptamine derivative in rats.","volume":"30","author":"Noworyta-Soko\u0142owska","year":"2016","journal-title":"Neurotox. Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11419-018-0433-x","article-title":"Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats.","volume":"37","author":"Noworyta-Soko\u0142owska","year":"2019","journal-title":"Forensic Toxicol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2690","article-title":"Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005\u20132017.","volume":"34","author":"Palamar","year":"2019","journal-title":"Hum. Psychopharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jat\/bku144","article-title":"Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.","volume":"39","author":"Pasin","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.npp.1300819","article-title":"Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.","volume":"31","author":"Pehek","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jat\/bku005","article-title":"High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.","volume":"38","author":"Poklis","year":"","journal-title":"J. Anal. Toxicol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/jat\/bkv079","article-title":"Identification of metabolite biomarkers of the designer hallucinogen 25I-NBOMe in mouse hepatic microsomal preparations and human urine samples associated with clinical intoxication.","volume":"39","author":"Poklis","year":"","journal-title":"J. Anal. Toxicol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.forsciint.2013.10.015","article-title":"Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.","volume":"234","author":"Poklis","year":"","journal-title":"Forensic Sci. Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jat\/bkv073","article-title":"Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and other dimethoxyphenyl-N-[(2-methoxyphenyl)methyl]ethanamine derivatives on blotter paper.","volume":"39","author":"Poklis","year":"","journal-title":"J. Anal. Toxicol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00528","article-title":"Dark classics in chemical neuroscience: NBOMes.","author":"Poulie","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/1556-4029.13433","article-title":"Drug recognition evaluation and chemical confirmation of a 25C-NBOMe-impaired driver.","volume":"62","author":"Rajotte","year":"2017","journal-title":"J. Forensic Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.toxac.2017.01.001","article-title":"Retrospective identification of 25I-NBOMe metabolites in an intoxication case.","volume":"29","author":"Richeval","year":"2017","journal-title":"Toxicol. Anal. Clin."},{"key":"B79","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11419-019-00498-7","article-title":"In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives: phase I and II metabolism, plasma protein binding and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry.","volume":"38","author":"Richter","year":"2019","journal-title":"Forensic Toxicol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/15563650.2013.772191","article-title":"A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug.","volume":"51","author":"Rose","year":"2013","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/bf00441948","article-title":"Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.","volume":"98","author":"Sadzot","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0091-3057(88)90390-5","article-title":"Serotonergic\u2013dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d).","volume":"31","author":"Schechter","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B85","first-page":"043","article-title":"A case of laboratory confirmed 25I-Nbome intoxication associated with massive rhabdomyolysis and multi-organ failure.","volume":"1","author":"Schetz","year":"2017","journal-title":"Adv. J. Toxicol. Curr. Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0304-3940(03)00547-0","article-title":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.","volume":"346","author":"Scruggs","year":"2003","journal-title":"Neurosci. Lett."},{"key":"B87","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00414-018-1904-7","article-title":"Metabolic profile determination of 25N-NBOMe in human liver microsomes by liquid chromatography-quadrupole time-of-flight mass spectrometry.","volume":"133","author":"Seo","year":"2019","journal-title":"Int. J. Legal Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainresbull.2019.07.002","article-title":"A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents.","volume":"152","author":"Seo","year":"2019","journal-title":"Brain Res. Bull."},{"key":"B89","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/jat\/bkv058","article-title":"Fatal intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014.","volume":"39","author":"Shanks","year":"2015","journal-title":"J Anal. Toxicol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1556-4029.13583","article-title":"Experimental study on the postmortem redistribution of the substituted phenethylamine, 25B-NBOMe.","volume":"63","author":"Shintani-Ishida","year":"2018","journal-title":"J. Forensic Sci."},{"key":"B91","author":"Shulgin","year":"1991","journal-title":"Phenethylamines I Have Known and Loved (PiHKAL)."},{"key":"B92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10822-010-9400-2","article-title":"Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor.","volume":"25","author":"Silva","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B93","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/dta.1576","article-title":"An investigation of the stability of emerging new psychoactive substances.","volume":"6","author":"Soh","year":"2014","journal-title":"Drug Test. Anal."},{"key":"B94","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3109\/15563650.2015.1054502","article-title":"NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System.","volume":"53","author":"Srisuma","year":"2015","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.","volume":"10","author":"Stellpflug","year":"2014","journal-title":"J. Med. Toxicol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion\u2013a novel class of potent hallucinogens: A review of the literature.","volume":"56","author":"Suzuki","year":"2015","journal-title":"Psychosomatics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/02791072.2014.960111","article-title":"\u201cMy friend said it was good LSD\u201d: a suicide attempt following analytically confirmed 25I-NBOMe ingestion.","volume":"46","author":"Suzuki","year":"2014","journal-title":"J. Psychoactive Drugs"},{"key":"B98","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/15563650.2014.909932","article-title":"Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe.","volume":"52","author":"Tang","year":"2014","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B99","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/jat\/bkx029p","article-title":"Metabolic profile determination of NBOMe compounds using human liver microsomes and comparison with findings in authentic human blood and urine.","volume":"41","author":"Temporal","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/bf00176847","article-title":"Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.","volume":"94","author":"Titeler","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"B101","year":""},{"key":"B102","year":""},{"key":"B103","year":""},{"key":"B104","year":""},{"key":"B105","year":""},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.82.10_supplement.P1.342","article-title":"Fatal outcome of status epilepticus, hyperthermia, rhabdomyolysis, multi-organ failure, and cerebral edema after 25I-NBOMe ingestion.","author":"Umemura","year":"2014","journal-title":"Neurology"},{"key":"B107","year":"2019","journal-title":"Current NPS Threats (2019) 1."},{"key":"B108","year":"2019","journal-title":"United Nations Office on Drugs and Crime. World Drug Report 2019. Booklet 5. Cannabis and Hallucinogens."},{"key":"B109","year":"2017","journal-title":"World Drug Report 2017. Booklet 4. Market Analysis of Synthetic Drugs. Amphetamine-Type Stimulants, New Psychoactive Substances."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"B111","first-page":"533","article-title":"Serotonin syndrome.","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"},{"key":"B112","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","article-title":"Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.","volume":"35","author":"Walterscheid","year":"2014","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2016.12.018","article-title":"Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS\/MS in case of severe intoxications.","volume":"104","author":"Wiergowski","year":"2017","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"B114","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/jat\/bkx055","article-title":"A validated method for the detection of 32 Bath Salts in oral fluid.","volume":"41","author":"Williams","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"B115","first-page":"699","article-title":"Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.","volume":"282","author":"Willins","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B116","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/dta.2044","article-title":"25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.","volume":"9","author":"Wohlfarth","year":"2017","journal-title":"Drug Test. Anal."},{"key":"B117","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/15563650.2015.1004179","article-title":"Prevalence of use and acute toxicity associated with the use of NBOMe drugs.","volume":"53","author":"Wood","year":"2015","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B118","article-title":"25B\u2212NBOMe critical review report agenda item 4.17","year":"","journal-title":"Proceedings of the Expert Committee on Drug Dependence Thirty-sixth Meeting 16\u221220 June 2014"},{"key":"B119","article-title":"25I\u2212NBOMe Critical Review Report Agenda item 4.19","year":"","journal-title":"Proceedings of the Expert Committee on Drug Dependence Thirty-sixth Meeting 16\u221220 June 2014"},{"key":"B120","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s12640-019-0012-x","article-title":"25C-NBOMe, a novel designer psychedelic, induces neurotoxicity 50 times more potent than methamphetamine in vitro.","volume":"35","author":"Xu","year":"2019","journal-title":"Neurotox. Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.toxlet.2019.01.004","article-title":"2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo.","volume":"304","author":"Yoon","year":"2019","journal-title":"Toxicol. Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1021\/acs.analchem.9b00294","article-title":"MS-based molecular networking of designer drugs as an approach for the detection of unknown derivatives for forensic and doping applications: A case of NBOMe derivatives.","volume":"91","author":"Yu","year":"2019","journal-title":"Anal. Chem."},{"key":"B123","year":"2016"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4172\/2090-2697.1000138","article-title":"Seized blotters containing one regioisomer of 25I-NBOMe.","volume":"9","author":"Zhang","year":"2018","journal-title":"J. Forensic Biomed"},{"key":"B125","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.forsciint.2012.08.027","article-title":"25C-NBOMe \u2013 new potent hallucinogenic substance identified on the drug market.","volume":"227","author":"Zuba","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"B126","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neuro.2018.03.00","article-title":"Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA).","volume":"66","author":"Zwartsen","year":"2018","journal-title":"Neurotoxicology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuro.2019.05.004","article-title":"Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios.","volume":"74","author":"Zwartsen","year":"2019","journal-title":"Neurotoxicology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5811\/cpcem.2017.5.33994","article-title":"25C-NBOMe ingestion.","volume":"1","author":"Zygowiec","year":"2017","journal-title":"Clin. Pract. Cases Emerg. Med."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T23:35:57Z","timestamp":1722468957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":128,"alternative-id":["10.3389\/fnins.2020.00078"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00078","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,26]]},"article-number":"78"}}